NCT03925116View on ClinicalTrials.gov

Contraceptive Pathway and Contraception Continuation Rates

NASuspendedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 3, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Contraceptive Usage
Interventions
OTHER

COntraceptive pathway

alternative way of aiding patients in deciding contraception method

Trial Locations (1)

08901

Clinical Academic Building. 125 Paterson Street, New Brunswick

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Rutgers, The State University of New Jersey

OTHER

NCT03925116 - Contraceptive Pathway and Contraception Continuation Rates | Biotech Hunter | Biotech Hunter